Sumitro Khadijah Rizky, Utomo Martono Tri, Widodo Agung Dwi Wahyu
Department of Child Health, Faculty of Medicine, Universitas Airlangga- Dr. Soetomo Hospital, Surabaya, Indonesia.
Department of Clinical Microbiology, Faculty of Medicine, Universitas Airlangga- Dr. Soetomo Hospital, Surabaya, Indonesia.
Oman Med J. 2021 Jan 6;36(1):e214. doi: 10.5001/omj.2021.05. eCollection 2021 Jan.
We sought to analyze the neutrophil-to-lymphocyte ratio (NLR) as an alternative marker of neonatal sepsis.
In this cross-sectional study, we undertook consecutive sampling in all inborn neonates admitted to the Neonatal Intensive Care Unit with clinical manifestations of neonatal sepsis. Neonates with congenital anomalies and referred neonates were excluded. Complete blood count, C-reactive protein (CRP), and blood culture were carried out as the septic workup examinations based on the local Clinical Practical Guidelines. NLR is obtained by dividing the absolute count of neutrophils from lymphocytes manually. A cut-off value of NLR is obtained using a receiver operating characteristic curve.
The median NLR value of the 104 neonates who met the inclusion and exclusion criteria was 3.63 (2.39-6.12). Neonates with NLR of 2.12 have the area under the curve of 0.630 (95% confidence interval (CI): 0.528-0.741) and 0.725 (95% CI: 0.636-0.814) when combined with CRP = 2.70 mg/dL. Neonates with NLR ≥ 2.12 in clinical neotnatal sepsis had almost double the risk of providing positive blood culture results (relative risk = 1.867, 95% CI: 1.077-3.235; 0.011).
NLR, calculated from complete blood count, can be used as an alternative marker of easy and relatively inexpensive neonatal sepsis, especially in developing countries, and detection of proven neonatal sepsis to be better when combined with CRP.
我们试图分析中性粒细胞与淋巴细胞比值(NLR)作为新生儿败血症的替代标志物。
在这项横断面研究中,我们对入住新生儿重症监护病房且有新生儿败血症临床表现的所有足月儿进行连续抽样。排除患有先天性畸形的新生儿和转诊新生儿。根据当地临床实践指南,进行全血细胞计数、C反应蛋白(CRP)和血培养作为败血症检查。NLR通过手动将中性粒细胞绝对计数除以淋巴细胞计数获得。使用受试者工作特征曲线获得NLR的临界值。
符合纳入和排除标准的104例新生儿的NLR中位数为3.63(2.39 - 6.12)。NLR为2.12的新生儿与CRP = 2.70 mg/dL联合时,曲线下面积为0.630(95%置信区间(CI):0.528 - 0.741)和0.725(95%CI:0.636 - 0.814)。临床新生儿败血症中NLR≥2.12的新生儿血培养结果呈阳性的风险几乎加倍(相对风险 = 1.867,95%CI:1.077 - 3.235;P = 0.011)。
根据全血细胞计数计算得出的NLR可作为一种简便且相对廉价的新生儿败血症替代标志物,尤其在发展中国家,与CRP联合使用时对确诊新生儿败血症的检测效果更佳。